The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s application to expand the indications for certain pacemakers and defibrillators for patients with heart failure. The ...
"It is unknown at this time if there will be additional litigation surrounding this specific product," Rosalie Louis of Lynch ...
Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...
The U.S. Food and Drug Administration issued its most serious type of recall for 348,616 Medtronic defibrillators, saying they are at risk for delivering "a reduced-energy shock or no shock at all," ...
Medtronic is recalling nearly 350,000 implantable cardiac devices due to continued problems with the delivery of high-voltage energy, according to an announcement from the US Food and Drug ...
Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...
Fridley, Minn.-based Medtronic has agreed to pay $23.5 million to settle allegations that it paid kickbacks to physicians to induce their use of company pacemakers and defibrillators, according to a ...
TEL AVIV (MarketWatch) -- Medtronic Inc., the Minneapolis medical-technology company, said on Monday that it would voluntarily suspend distribution of the Sprint Fidelis family of defibrillation leads ...
Seven years after bringing the world's first leadless pacemaker (shown above) to the U.S. market, Medtronic has once again set a new pace in the industry with its next-generation leadless pacemakers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback